Inventor · disambiguated record
Sarkiz Issakani
Also filed as: ISSAKANI SARKIZ · ISSAKANI SARKIZ D
12 granted patents·7 pending applications·203 citations·filing 2000–2022
91Inventor score
Top patents by PatentIndex Score
19 records- 0194US7153880B2Substituted diphenyl heterocycles useful for treating HCV infectionRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Dec 26, 2006·68 cites·15 claims
- 0292US7915293B2Ubiquitin ligase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Mar 29, 2011·42 cites·14 claims
- 0391US6737244B2Ubiquitin ligase assayRIGEL PHARMACEUTICALS INC·Filed 2001·Granted May 18, 2004·36 cites·43 claims
- 0488US6740495B1Ubiquitin ligase assayRIGEL PHARMACEUTICALS INC·Filed 2000·Granted May 25, 2004·27 cites·19 claims
- 0580US6919184B2Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agentsRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Jul 19, 2005·8 cites·17 claims
- 0677US7022493B2Ubiquitin conjugation assaysRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Apr 4, 2006·10 cites·20 claims
- 0775US7566732B2Rhodanine compositions for use as antiviral agentsRIGEL PHARMACEUTICALS INC·Filed 2004·Granted Jul 28, 2009·7 cites·3 claims
- 0867US6979551B2Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agentsRIGEL PHARMACEUTICALS INC·Filed 2002·Granted Dec 27, 2005·5 cites·33 claims
- 0965US7781182B2Ubiquitin ligase assayRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Aug 24, 2010·0 cites·27 claims
- 1065US2022098175A1Direct ampk activatorsRIGEL PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1157US2022152065A1Method of blocking or ameliorating cytokine release syndromeRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1255US7524642B2Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agentsRIGEL PHARMACEUTICALS INC·Filed 2006·Granted Apr 28, 2009·0 cites·17 claims
- 1355US2022249475A1Compounds and method for treating cytokine release syndromeRIGEL PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1454US2009263831A1Ubiquitin ligase assayISSAKANI SARKIZ D·Filed 2006·Application pending·0 cites
- 1553US2006276520A1Rhodanine derivatives and pharmaceutical compositions containing themRIGEL PHARMACEUTICALS INC·Filed 2003·Application pending·0 cites
- 1651US2006115864A1Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agentsRIGEL PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1750US11174246B2Direct AMPK activatorsRIGEL PHARMACEUTICALS INC·Filed 2017·Granted Nov 16, 2021·0 cites·33 claims
- 1841US2006160869A1Ubiquitin ligase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1934US10040766B2Ubiquitination inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2015·Granted Aug 7, 2018·0 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →